FFCP PHASE1:Mm9::chr10:6486850..6486860,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=70|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr10:6486850..6486860,-|id=chr10:6486850..6486860,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000473!1.92e-26!14;UBERON:0003135!1.01e-24!15;UBERON:0003101!3.24e-23!16;UBERON:0000079!3.24e-23!16;UBERON:0004176!6.92e-22!17;UBERON:0009196!6.92e-22!17;UBERON:0009117!6.92e-22!17;UBERON:0000991!1.05e-20!18;UBERON:0005564!1.05e-20!18;UBERON:0003133!1.15e-15!24;UBERON:0005156!1.68e-14!26;UBERON:0000990!1.68e-14!26;UBERON:0002323!2.52e-10!37;UBERON:0004458!2.52e-10!37;UBERON:0003886!4.59e-10!38;UBERON:0002553!8.12e-10!39;UBERON:0000464!7.94e-07!57|ontology_enrichment_uberon_v019_2=UBERON:0000473,1.51e-31,14;UBERON:0003135,1.68e-29,15;UBERON:0003101,1.04e-27,16;UBERON:0000079,1.04e-27,16;UBERON:0004176,3.95e-26,17;UBERON:0009196,3.95e-26,17;UBERON:0009117,3.95e-26,17;UBERON:0000991,1.01e-24,18;UBERON:0005564,1.01e-24,18;UBERON:0003133,9.72e-19,24;UBERON:0005156,2.36e-17,26;UBERON:0000990,2.36e-17,26;UBERON:0002323,2.12e-12,37;UBERON:0004458,2.12e-12,37;UBERON:0003886,4.33e-12,38;UBERON:0002553,8.52e-12,39|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.595303031057488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.12738587736838,0,0,0,0,0,0,1.17183946359555,3.77493639932559,3.8653459332161,2.88030006257865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr10:6486850..6486860,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=70 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:6486850..6486860,- | |||
|description=CAGE_peak_at_chr10:6486850..6486860,- | |||
|id=chr10:6486850..6486860,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000473!1.92e-26!14;UBERON:0003135!1.01e-24!15;UBERON:0003101!3.24e-23!16;UBERON:0000079!3.24e-23!16;UBERON:0004176!6.92e-22!17;UBERON:0009196!6.92e-22!17;UBERON:0009117!6.92e-22!17;UBERON:0000991!1.05e-20!18;UBERON:0005564!1.05e-20!18;UBERON:0003133!1.15e-15!24;UBERON:0005156!1.68e-14!26;UBERON:0000990!1.68e-14!26;UBERON:0002323!2.52e-10!37;UBERON:0004458!2.52e-10!37;UBERON:0003886!4.59e-10!38;UBERON:0002553!8.12e-10!39;UBERON:0000464!7.94e-07!57 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000473,1.51e-31,14;UBERON:0003135,1.68e-29,15;UBERON:0003101,1.04e-27,16;UBERON:0000079,1.04e-27,16;UBERON:0004176,3.95e-26,17;UBERON:0009196,3.95e-26,17;UBERON:0009117,3.95e-26,17;UBERON:0000991,1.01e-24,18;UBERON:0005564,1.01e-24,18;UBERON:0003133,9.72e-19,24;UBERON:0005156,2.36e-17,26;UBERON:0000990,2.36e-17,26;UBERON:0002323,2.12e-12,37;UBERON:0004458,2.12e-12,37;UBERON:0003886,4.33e-12,38;UBERON:0002553,8.52e-12,39 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.595303031057488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.12738587736838,0,0,0,0,0,0,1.17183946359555,3.77493639932559,3.8653459332161,2.88030006257865,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr10:6486850..6486860,- | |||
}} |
Latest revision as of 14:37, 4 August 2015
Short description: | p@chr10:6486850..6486860, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:6486850..6486860, - |
Coexpression cluster: | MCL_coexpression_mm9:70 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
testis | 1.51e-31 | 14 |
male reproductive organ | 1.68e-29 | 15 |
male organism | 1.04e-27 | 16 |
male reproductive system | 1.04e-27 | 16 |
external genitalia | 3.95e-26 | 17 |
indifferent external genitalia | 3.95e-26 | 17 |
indifferent gonad | 3.95e-26 | 17 |
gonad | 1.01e-24 | 18 |
gonad primordium | 1.01e-24 | 18 |
reproductive organ | 9.72e-19 | 24 |
reproductive structure | 2.36e-17 | 26 |
reproductive system | 2.36e-17 | 26 |
body cavity | 2.12e-12 | 37 |
body cavity or lining | 2.12e-12 | 37 |
body cavity precursor | 4.33e-12 | 38 |
anatomical cavity | 8.52e-12 | 39 |